GLP-1 medication for lung function and muscle health in COPD
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Lungs & breathing clinical trials.
This study tests whether a GLP-1 medication (a type of drug that helps with weight and blood sugar) can improve lung function and muscle strength in people with COPD who are overweight or have weight-related health problems. It may offer a new way to treat both breathing and muscle issues in COPD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have been diagnosed with COPD and your lung function is moderate (not too mild or too severe).
- You used to smoke, and have smoked at least one pack a day for 10 years or more.
- Your body mass index (BMI) is 27 or higher, and you have at least one weight-related health problem (like high blood pressure or sleep apnea), OR your BMI is between 30 and 40.
- You do not have type 2 diabetes, active cancer, or a history of pancreatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining a newer weight-loss medication (tirzepatide) with a structured exercise program helps improve muscle strength and function in people who are overweight or obese. Researchers will measure changes in muscle quality and physical fitness over time.
This trial tests a medicine called tirzepatide, given as an injection, to see if it can improve daily function and symptoms in people with a weak heart (heart failure with reduced ejection fraction) who also have obesity. Tirzepatide works on two natural hormones to help with weight and may also improve heart health.
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.
This study tests if the drug tirzepatide can improve muscle and blood vessel health in older adults with obesity. You may be eligible if you are 50 or older, have a BMI between 30 and 40, and do not have diabetes.
This study tests a medication called tirzepatide (a type of GLP-1 drug) to see how it affects muscle and bone health during weight loss. It is for people with obesity who are not menopausal and do not have diabetes or bone disease.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.